DOX-AL ITALIA S.p.A.
Group Technical Centre
Sede Legale/Legal Seat: Via dei Giardini, 4 – 20121 Milano – ITALY
Uffici/Office: Via Mascagni, 6/A – 20050 Sulbiate Superiore (MI) – ITALY
DOX-AL AUSTRALIA PTY. LTD.
Head Office: 21 Terrara Road, Vermont, Victoria, Australia 3133
Telephone: +61 3 9874 1892 Facsimile: +61 3 9873 4194 email: email@example.com
New South wales Office: 15 Railway parade, Balmoral Village, NSW Australia 2571
Telephone: 0418 651 218 Facsimile: +61 2 486899 004
THE DOX-AL GROUP IS LOCATED IN 60 COUNTRIES SPEAD ACCROSS THE GLOBE
What are the benefits of feeding Thepax? How does Thepax differ from live or dried yeast?
The microflora of the digestive tract contributes to the digestive There are numerous factors that influence the viability of any yeast product.
processes of the animal by production of specific enzymes able to
induce the release of nutrients that would otherwise be inaccessible, for Live yeast is generally destroyed at the gastric barrier and evidence
example those bound to vegetal fibre. indicates it may activate the defence mechanisms of the indigenous flora.
While some increase in micro-flora is evident initially the colony is ultimately
The digestive microflora synthesise substances (vitamins, amino-acids reduced.
etc), which play an important role in the metabolism of the animal.
Dried yeasts contain nutrients that are typically destroyed as a result of the
Stimulating the digestive microflora with Thepax inactivated and drying process. Dried yeast has only marginal effect on the growth of
stabilised saccharomyces cerevaise, enhances the capability of the digestive micro-organisms.
animal to utilise the feed, thus improving the feed efficiency.
Thepax has been used successfully for over 10 years and has been proven
This leads to: the most effective product of its type available in the market today.
Increased production performance (milk & meat etc)
Improved FCR An invitro trial at the University of Perugia’s Department of Internal Medicine
Decreased production unit cost on the growth of treated and untreated lactobacilli acidophilus over a 24
Improved product quality (milk, meat etc) hour period highlighted that the normal growth of an untreated colony
Reduction in the use of antibiotics starting at 0.0634 (spectrumphotometer at 600nm) peaked at 11 hours at
117% increase, reducing to 32% at 24 hours.
The addition of Diamond V (dried yeast) increased the colony by 146.8% at
Mode of action of Thepax 11 hours, reducing to 61% at 24 hours.
The addition of live yeast increased the colony by 145.5% at 11 hours
The unique and patented method of inactivation and stabilization of the reducing to just 17% at 24 hours.
saccharomyces cerevaise cells present a unique product with unparallel
benefits. The addition of Thepax (inactivated and stabilised saccharomyces
cerevaise, increased the colony by 641% at 11 hours reducing to just 553%
The carrier-cell transports essential nutrients to the digestive at 24 hours.
microorganism, which break down the cell wall by enzymatic attack.
The patented inactivation and stabilisation process of the saccharomyces
Studies have shown, that this lysis may only be carried out by bacterial cerevaise cells in Thepax ensures the cells arrive intact in the gut to allow
enzymes, while the ones produced by the host animal are ineffective. maximum utilisation by the indigenous micro flora
Fig 1: Graph of the growth curve of lactobacilli acidophilus
The digestive bacteria are able to use the substances contained in the
carrier-cell (Thepax) as nutrients, enhancing their own important
The resulting increase in cellular synthesis, catabolism and cellular
reproduction benefit the host animal by improving digestive efficiency
and immune defence.